All Stories

  1. Longitudinal Assessment of Body Composition and Inflammatory Status in Rheumatoid Arthritis During TNF Inhibitor Treatment: A Pilot Study

    Article • International Journal of Molecular Sciences, August 2025, MDPI AG

    Professor Antonio Fernandez-Nebro

  2. Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort

    Article • Lupus Science & Medicine, July 2025, BMJ

    Professor Antonio Fernandez-Nebro

  3. Identifying inflammatory phenotypes associated with lung involvement in systemic sclerosis: k-means clustering approach

    Article • Frontiers in Immunology, May 2025, Frontiers

    Professor Antonio Fernandez-Nebro

  4. DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case–control study

    Article • Scientific Reports, April 2025, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  5. Impact of TNF inhibitors on inflammation-associated cognitive dysfunction in patients with rheumatoid arthritis: a prospective analysis

    Article • Frontiers in Medicine, April 2025, Frontiers

    Dr Pedro Jesus Serrano-Castro, Professor Antonio Fernandez-Nebro

  6. Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

    Article • Lupus, April 2025, SAGE Publications

    Professor Antonio Fernandez-Nebro

  7. Accrual of organ damage and one-year mortality in systemic sclerosis: A prospective observational study

    Article • Seminars in Arthritis and Rheumatism, February 2025, Elsevier

    Professor Antonio Fernandez-Nebro

  8. Gut dysbiosis is associated with difficult-to-treat rheumatoid arthritis

    Article • Frontiers in Medicine, January 2025, Frontiers

    Professor Antonio Fernandez-Nebro

  9. EducAR: implementing a multicomponent strategy to improve therapeutic adherence in rheumatoid arthritis

    Article • RMD Open, January 2025, BMJ

    Professor Antonio Fernandez-Nebro

  10. Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)

    Article • Rheumatology International, August 2024, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  11. Intestinal Dysbiosis, Tight Junction Proteins, and Inflammation in Rheumatoid Arthritis Patients: A Cross-Sectional Study

    Article • International Journal of Molecular Sciences, August 2024, MDPI AG

    Professor Antonio Fernandez-Nebro

  12. Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis

    Article • Lupus Science & Medicine, August 2024, BMJ

    Professor Antonio Fernandez-Nebro

  13. Impact of inflammation on cognitive function in patients with highly inflammatory rheumatoid arthritis

    Article • RMD Open, June 2024, BMJ

    Professor Antonio Fernandez-Nebro

  14. Impact of the COVID-19 pandemic on psychosocial health in rheumatic patients: A longitudinal study

    Article • Reumatología Clínica, June 2024, Elsevier

    Professor Antonio Fernandez-Nebro

  15. Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus

    Article • Reumatología Clínica, June 2024, Elsevier

    Professor Antonio Fernandez-Nebro

  16. Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs

    Article • Biomedicine & Pharmacotherapy, April 2024, Elsevier

    Professor Antonio Fernandez-Nebro

  17. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Article • Lupus Science & Medicine, April 2024, BMJ

    Professor Antonio Fernandez-Nebro

  18. Severity and impact of digestive impairment perceived by patients with systemic sclerosis: a cross-sectional study

    Article • BMJ Open, April 2024, BMJ

    Professor Antonio Fernandez-Nebro

  19. Rate of severe and fatal infections in a cohort of patients with interstitial lung disease associated with rheumatoid arthritis: a multicenter prospective study

    Article • Frontiers in Immunology, March 2024, Frontiers

    Professor Antonio Fernandez-Nebro

  20. Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes

    Article • Genome Biology, March 2024, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  21. Interstitial Lung Disease Is Associated with Sleep Disorders in Rheumatoid Arthritis Patients

    Article • Clocks & Sleep, December 2023, MDPI AG

    Professor Antonio Fernandez-Nebro

  22. Prevalence of Malnutrition and Associated Factors in Older Patients with Rheumatoid Arthritis: A Cross-Sectional Study

    Article • Nutrients, August 2023, MDPI AG

    Professor Antonio Fernandez-Nebro

  23. Sarcopenia and Nutrition in Elderly Rheumatoid Arthritis Patients: A Cross-Sectional Study to Determine Prevalence and Risk Factors

    Article • Nutrients, May 2023, MDPI AG

    Professor Antonio Fernandez-Nebro

  24. Inflammatory Biomarkers in the Diagnosis and Prognosis of Rheumatoid Arthritis–Associated Interstitial Lung Disease

    Article • International Journal of Molecular Sciences, April 2023, MDPI AG

    Professor Antonio Fernandez-Nebro

  25. Adiposity is associated with expansion of the genus Dialister in rheumatoid arthritis patients

    Article • Biomedicine & Pharmacotherapy, April 2023, Elsevier

    Professor Antonio Fernandez-Nebro

  26. Analysis of comorbidity in rheumatoid arthritis–associated interstitial lung disease: a nested case-cohort study

    Article • Biomedicine & Pharmacotherapy, January 2023, Elsevier

    Professor Antonio Fernandez-Nebro

  27. Using natural language processing to explore characteristics and management of patients with axial spondyloarthritis and psoriatic arthritis treated under real-world conditions in Spain: SpAINET study

    Article • Therapeutic Advances in Musculoskeletal Disease, January 2023, SAGE Publications

    Professor Antonio Fernandez-Nebro

  28. Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting

    Article • Reumatología Clínica, December 2022, Elsevier

    Professor Antonio Fernandez-Nebro

  29. Inflammatory profile of incident cases of late-onset compared with young-onset rheumatoid arthritis: A nested cohort study

    Article • Frontiers in Medicine, November 2022, Frontiers

    Professor Antonio Fernandez-Nebro

  30. Relación entre poliautoinmunidad y obesidad sarcopénica en pacientes con artritis reumatoide

    Article • Reumatología Clínica, November 2022, Elsevier

    Professor Antonio Fernandez-Nebro

  31. miRNA-Mediated Epigenetic Regulation of Treatment Response in RA Patients—A Systematic Review

    Article • International Journal of Molecular Sciences, October 2022, MDPI AG

    Professor Antonio Fernandez-Nebro

  32. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    Article • npj Genomic Medicine, October 2022, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  33. Collinsella is associated with cumulative inflammatory burden in an established rheumatoid arthritis cohort

    Article • Biomedicine & Pharmacotherapy, September 2022, Elsevier

    Professor Antonio Fernandez-Nebro

  34. Hospitalizaciones y mortalidad por COVID-19 en pacientes con enfermedades inflamatorias reumáticas en Andalucía

    Article • Reumatología Clínica, August 2022, Elsevier

    Professor Antonio Fernandez-Nebro

  35. Longitudinal Study of Cognitive Functioning in Adults with Juvenile Idiopathic Arthritis

    Article • Biomedicines, July 2022, MDPI AG

    Dr Pedro Jesus Serrano-Castro, Professor Antonio Fernandez-Nebro

  36. Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease

    Article • Biomedicines, June 2022, MDPI AG

    Professor Antonio Fernandez-Nebro

  37. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

    Article • EBioMedicine, June 2022, Elsevier

    Professor Antonio Fernandez-Nebro

  38. Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

    Article • Journal of Clinical Medicine, May 2022, MDPI AG

    Professor Antonio Fernandez-Nebro

  39. Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study

    Article • Rheumatology, April 2022, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  40. Importance of Vaccination against SARS-CoV-2 in Patients with Interstitial Lung Disease Associated with Systemic Autoimmune Disease

    Article • Journal of Clinical Medicine, April 2022, MDPI AG

    Professor Antonio Fernandez-Nebro

  41. Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study

    Article • Journal of Clinical Medicine, February 2022, MDPI AG

    Professor Antonio Fernandez-Nebro

  42. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Article • Seminars in Arthritis and Rheumatism, February 2022, Elsevier

    Professor Antonio Fernandez-Nebro

  43. Postprandial Hyperlipidemia: Association with Inflammation and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

    Article • Biomedicines, January 2022, MDPI AG

    Professor Antonio Fernandez-Nebro

  44. Ability to Participate in Social Activities of Rheumatoid Arthritis Patients Compared with Other Rheumatic Diseases: A Cross-Sectional Observational Study

    Article • Diagnostics, December 2021, MDPI AG

    Professor Antonio Fernandez-Nebro

  45. Efectividad, seguridad y análisis económico de Benepali en práctica clínica

    Article • Reumatología Clínica, December 2021, Elsevier

    Professor Antonio Fernandez-Nebro

  46. Seven chain adaptive immune receptor repertoire analysis in rheumatoid arthritis: association to disease and clinically relevant phenotypes

    Article • November 2021, Cold Spring Harbor Laboratory Press

    Professor Antonio Fernandez-Nebro

  47. Meningoencefalitis por Cryptococcus neoformans y virus varicela-zoster en paciente con lupus eritematoso sistémico

    Article • Neurología, November 2021, Elsevier

    Professor Antonio Fernandez-Nebro

  48. Characteristics and Predictors of Progression Interstitial Lung Disease in Rheumatoid Arthritis Compared with Other Autoimmune Disease: A Retrospective Cohort Study

    Article • Diagnostics, September 2021, MDPI AG

    Professor Antonio Fernandez-Nebro

  49. Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis

    Article • Rheumatology, September 2021, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  50. Human motion capture for movement limitation analysis using an RGB-D camera in spondyloarthritis: a validation study

    Article • Medical & Biological Engineering & Computing, September 2021, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  51. Adiposity Is Related to Inflammatory Disease Activity in Juvenile Idiopathic Arthritis

    Article • Journal of Clinical Medicine, August 2021, MDPI AG

    Professor Antonio Fernandez-Nebro

  52. Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double‐Blind Withdrawal Study

    Article • Arthritis & Rheumatology, August 2021, Wiley

    Professor Antonio Fernandez-Nebro

  53. Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?

    Article • Rheumatology, May 2021, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  54. Aportaciones del registro de lupus de la Sociedad Española de Reumatología (RELESSER) al conocimiento del lupus eritematoso sistémico en España

    Article • Reumatología Clínica, May 2021, Elsevier

    Professor Antonio Fernandez-Nebro

  55. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study

    Article • European Journal of Clinical Nutrition, April 2021, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  56. Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

    Article • BMC Musculoskeletal Disorders, April 2021, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  57. Correction to: Utility of pulmonary ultrasound to identify interstitial lung disease in patients with rheumatoid arthritis

    Article • Clinical Rheumatology, April 2021, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  58. Análisis de las características clínico-analíticas de pacientes con artritis reumatoide y enfermedad pulmonar intersticial: casos y controles

    Article • Reumatología Clínica, April 2021, Elsevier

    Professor Antonio Fernandez-Nebro

  59. Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis

    Article • Frontiers in Immunology, March 2021, Frontiers

    Professor Antonio Fernandez-Nebro

  60. Utility of pulmonary ultrasound to identify interstitial lung disease in patients with rheumatoid arthritis

    Article • Clinical Rheumatology, February 2021, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  61. Predictors of Progression and Mortality in Patients with Prevalent Rheumatoid Arthritis and Interstitial Lung Disease: A Prospective Cohort Study

    Article • Journal of Clinical Medicine, February 2021, MDPI AG

    Professor Antonio Fernandez-Nebro

  62. Cumulative inflammatory burden and obesity as determinants of insulin resistance in patients with established rheumatoid arthritis: cross-sectional study

    Article • BMJ Open, February 2021, BMJ

    Professor Antonio Fernandez-Nebro

  63. Incidence and case fatality rate of COVID‐19 in patients with inflammatory articular diseases

    Article • International Journal of Clinical Practice, December 2020, Wiley

    Professor Antonio Fernandez-Nebro

  64. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

    Article • Annals of the Rheumatic Diseases, December 2020, Elsevier

    Professor Antonio Fernandez-Nebro

  65. Psychological factors associated with sleep disorders in patients with axial spondyloarthritis or psoriatic arthritis: A multicenter cross‐sectional observational study

    Article • Journal of Clinical Nursing, November 2020, Wiley

    Professor Antonio Fernandez-Nebro

  66. Evaluation of cognitive function in adult patients with juvenile idiopathic arthritis

    Article • International Journal of Rheumatic Diseases, October 2020, Wiley

    Professor Antonio Fernandez-Nebro

  67. Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER)

    Article • Rheumatology, October 2020, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  68. Frequency of Polyautoimmunity in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus

    Article • JCR Journal of Clinical Rheumatology, September 2020, Wolters Kluwer Health

    Professor Antonio Fernandez-Nebro

  69. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality

    Article • Lupus, August 2020, SAGE Publications

    Professor Antonio Fernandez-Nebro

  70. Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

    Article • Journal of Clinical Medicine, August 2020, MDPI AG

    Professor Antonio Fernandez-Nebro

  71. Clinical Outcomes of Patients with COVID-19 and Chronic Inflammatory and Autoimmune Rheumatic Diseases: A Multicentric Matched-Cohort Study

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Professor Antonio Fernandez-Nebro

  72. Non-anti-TNF biologic agents are associated with slower worsening of interstitial lung disease secondary to rheumatoid arthritis

    Article • Clinical Rheumatology, June 2020, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  73. Prevalence of Hospital PCR Confirmed COVID-19 Cases in Patients with Chronic Inflammatory and Autoimmune Rheumatic Diseases

    Article • May 2020, Cold Spring Harbor Laboratory Press

    Professor Antonio Fernandez-Nebro

  74. Expansion of Rare and Harmful Lineages is Associated with Established Rheumatoid Arthritis

    Article • Journal of Clinical Medicine, April 2020, MDPI AG

    Professor Antonio Fernandez-Nebro

  75. Non–anti-TNF biologic agents not associated with a worsening of lung disease secondary to rheumatoid arthritis.

    Article • March 2020, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  76. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Article • Scientific Reports, February 2020, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  77. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus

    Article • Arthritis Care & Research, January 2020, Wiley

    Professor Antonio Fernandez-Nebro

  78. Clinical Outcomes of Patients with COVID-19 and Chronic Inflammatory and Autoimmune Rheumatic Diseases: A Multicentric Matched-Cohort Study

    Article • SSRN Electronic Journal, January 2020, Elsevier

    Professor Antonio Fernandez-Nebro

  79. Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry

    Article • Rheumatology, December 2019, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  80. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)

    Article • Lupus, December 2019, SAGE Publications

    Professor Antonio Fernandez-Nebro

  81. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Article • Nature Communications, October 2019, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  82. A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis

    Article • Frontiers in Immunology, July 2019, Frontiers

    Professor Antonio Fernandez-Nebro

  83. Eficacia y seguridad de rituximab en neuropatía vasculítica: revisión sistemática

    Article • Reumatología Clínica, May 2019, Elsevier

    Professor Antonio Fernandez-Nebro

  84. Impact of Comorbidity on Physical Function in Patients with Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics. Results from the CAR diovascular in rheu MA tology ( ...

    Article • Arthritis Care & Research, April 2019, Wiley

    Professor Antonio Fernandez-Nebro

  85. Bacteremia in systemic lupus erythematosus patients from RELESSER: risk factors, clinical and microbiological characteristics and outcomes

    Article • The Journal of Rheumatology, April 2019, The Journal of Rheumatology

    Professor Antonio Fernandez-Nebro

  86. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study

    Article • Reumatología Clínica, March 2019, Elsevier

    Professor Antonio Fernandez-Nebro

  87. Patrones de tratamiento biológico en pacientes con enfermedades articulares inflamatorias. Estudio retrospectivo de 4 años de seguimiento

    Article • Reumatología Clínica, January 2019, Elsevier

    Professor Antonio Fernandez-Nebro

  88. Análisis de la efectividad, seguridad y optimización de tocilizumab en una cohorte de pacientes con artritis reumatoide en práctica clínica

    Article • Reumatología Clínica, January 2019, Elsevier

    Professor Antonio Fernandez-Nebro

  89. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

    Article • Annals of the Rheumatic Diseases, December 2018, BMJ

    M.D.,Ph.D. Rubén Queiro, Professor Antonio Fernandez-Nebro

  90. Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations

    Article • Genome Medicine, December 2018, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  91. Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort

    Article • December 2018, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  92. Recomendaciones de experto sobre el bloqueo de la interleucina 6 en pacientes con artritis reumatoide

    Article • Reumatología Clínica, August 2018, Elsevier

    Professor Antonio Fernandez-Nebro

  93. Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus

    Article • May 2018, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  94. Expert recommendations on the psychological needs of patients with rheumatoid arthritis

    Article • Rheumatology International, May 2018, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  95. Cross-phenotype analysis of Immunochip data identifiesKDM4Cas a relevantlocusfor the development of systemic vasculitis

    Article • Annals of the Rheumatic Diseases, January 2018, BMJ

    Professor Antonio Fernandez-Nebro

  96. Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)

    Article • Annals of the Rheumatic Diseases, January 2018, BMJ

    Professor Antonio Fernandez-Nebro

  97. Genetic variation associated with cardiovascular risk in autoimmune diseases

    Article • PLOS One, October 2017, PLOS

    Professor Antonio Fernandez-Nebro

  98. An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis

    Article • The Journal of Rheumatology, July 2017, The Journal of Rheumatology

    Professor Antonio Fernandez-Nebro

  99. Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

    Article • The Lancet, July 2017, Elsevier

    Professor Antonio Fernandez-Nebro

  100. Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study

    Article • Rheumatology International, June 2017, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  101. Genome-wide pathway analysis identifies VEGF pathway association with oral ulceration in systemic lupus erythematosus

    Article • June 2017, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  102. Cardiovascular disease in immune-mediated inflammatory diseases

    Article • Medicine, June 2017, Wolters Kluwer Health

    Professor Antonio Fernandez-Nebro

  103. Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

    Article • The Lancet, June 2017, Elsevier

    Professor Antonio Fernandez-Nebro

  104. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Article • Journal of Clinical Lipidology, May 2017, Elsevier

    Professor Antonio Fernandez-Nebro

  105. Management of cardiovascular risk in systemic lupus erythematosus: a systematic review

    Article • Lupus, April 2017, SAGE Publications

    Professor Antonio Fernandez-Nebro

  106. Erratum: Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

    Article • Scientific Reports, April 2017, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  107. Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

    Article • Scientific Reports, March 2017, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  108. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

    Article • Arthritis & Rheumatology, January 2017, Wiley

    Professor Antonio Fernandez-Nebro

  109. Incidence, associated factors and clinical impact of severe infections in a large multicentric cohort of patients with Systemic Lupus Erythematosus

    Article • Seminars in Arthritis and Rheumatism, January 2017, Elsevier

    Professor Antonio Fernandez-Nebro

  110. Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study

    Article • Arthritis Care & Research, November 2016, Wiley

    Professor Antonio Fernandez-Nebro

  111. Documento de Recomendaciones de la Sociedad Española de Reumatología para el manejo clínico del paciente con artritis reumatoide que no puede utilizar metotrexato

    Article • Reumatología Clínica, November 2016, Elsevier

    Professor Antonio Fernandez-Nebro

  112. Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort

    Article • Lupus, October 2016, SAGE Publications

    Professor Antonio Fernandez-Nebro

  113. A functional variant of TLR10 modifies the activity of NFkB and may help predict a worse prognosis in patients with rheumatoid arthritis

    Article • October 2016, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  114. Urine metabolome profiling of immune-mediated inflammatory diseases

    Article • BMC Medicine, September 2016, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro, Professor Antonio Fernandez-Nebro

  115. Estándares de calidad asistencial para las consultas externas de reumatología. El proyecto EXTRELLA

    Article • Reumatología Clínica, September 2016, Elsevier

    Professor Antonio Fernandez-Nebro

  116. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies

    Article • Arthritis & Rheumatology, August 2016, Wiley

    Professor Antonio Fernandez-Nebro

  117. Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period o...

    Article • Annals of the Rheumatic Diseases, August 2016, BMJ

    Professor Antonio Fernandez-Nebro

  118. Evaluation of the impact of nursing clinics in the rheumatology services

    Article • Rheumatology International, July 2016, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  119. Identification ofIRX1as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study

    Article • Arthritis & Rheumatology, May 2016, Wiley

    Professor Jaume Bertranpetit, Professor Antonio Fernandez-Nebro

  120. Eficiencia de diferentes dosis de rituximab en la artritis reumatoide

    Article • Reumatología Clínica, May 2016, Elsevier

    Professor Antonio Fernandez-Nebro

  121. Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry

    Article • Rheumatology, March 2016, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  122. A genome-wide association study identifiesSLC8A3as a susceptibility locus for ACPA-positive rheumatoid arthritis

    Article • Rheumatology, March 2016, Oxford University Press (OUP)

    Professor Jaume Bertranpetit, Professor Antonio Fernandez-Nebro

  123. Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER)

    Article • Medicine, March 2016, Wolters Kluwer Health

    Professor Antonio Fernandez-Nebro

  124. Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritis

    Article • Clinical Rheumatology, November 2015, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  125. Influence ofTYK2in systemic sclerosis susceptibility: a newlocusin the IL-12 pathway

    Article • Annals of the Rheumatic Diseases, September 2015, BMJ

    Professor Antonio Fernandez-Nebro

  126. Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide

    Article • Reumatología Clínica, September 2015, Elsevier

    Professor Antonio Fernandez-Nebro

  127. Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review

    Article • Rheumatology, July 2015, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  128. Cardiovascular Events in Systemic Lupus Erythematosus

    Article • Medicine, July 2015, Wolters Kluwer Health

    Professor Antonio Fernandez-Nebro

  129. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project

    Article • Seminars in Arthritis and Rheumatism, June 2015, Elsevier

    Professor Antonio Fernandez-Nebro

  130. A deletion atADAMTS9-MAGI1locus is associated with psoriatic arthritis risk

    Article • Annals of the Rheumatic Diseases, May 2015, BMJ

    Professor Josep Ll. Gelpi, M.D.,Ph.D. Rubén Queiro, Professor Antonio Fernandez-Nebro

  131. Eficacia y seguridad de golimumab añadido a fármacos antirreumáticos modificadores de la enfermedad en artritis reumatoide. Resultados del estudio GO-MORE en España

    Article • Reumatología Clínica, May 2015, Elsevier

    Professor Antonio Fernandez-Nebro

  132. A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis

    Article • The Pharmacogenomics Journal, April 2015, Nature

    Professor Antonio Fernandez-Nebro

  133. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis

    Article • The Pharmacogenomics Journal, April 2015, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  134. Variation at FCGR2A and Functionally Related Genes Is Associated with the Response to Anti-TNF Therapy in Rheumatoid Arthritis

    Article • PLOS One, April 2015, PLOS

    Professor Antonio Fernandez-Nebro

  135. A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility

    Article • The American Journal of Human Genetics, April 2015, Elsevier

    Professor Antonio Fernandez-Nebro

  136. Rheumatoid arthritis response to treatment across IgG1 allotype – anti-TNF incompatibility: a case-only study

    Article • Arthritis Research & Therapy, March 2015, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  137. FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors

    Article • Pharmacogenomics, March 2015, Future Medicine

    Professor Antonio Fernandez-Nebro

  138. Comprehensive Description of Clinical Characteristics of a Large Systemic Lupus Erythematosus Cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) With Emphasis on Complete Versus Incomplete Lupus Differences

    Article • Medicine, January 2015, Wolters Kluwer Health

    Professor Antonio Fernandez-Nebro

  139. Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus

    Article • Lupus, December 2014, SAGE Publications

    Professor Antonio Fernandez-Nebro

  140. Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: A systematic review

    Article • Seminars in Arthritis and Rheumatism, October 2014, Elsevier

    Professor Antonio Fernandez-Nebro

  141. Tofacitinib versus Methotrexate in Rheumatoid Arthritis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2014, New England Journal of Medicine (NEJM/MMS)

    Professor Antonio Fernandez-Nebro

  142. The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB)

    Article • Lupus, May 2014, SAGE Publications

    Professor Antonio Fernandez-Nebro

  143. Tocilizumab en pacientes con artritis reumatoide activa y respuesta inadecuada a fármacos antirreumáticos modificadores de la enfermedad o antagonistas del factor de necrosis tumoral: subanálisis de los datos españoles de un estudio abierto cercano a l...

    Article • Reumatología Clínica, March 2014, Elsevier

    Professor Antonio Fernandez-Nebro

  144. Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

    Article • Pharmacogenetics and Genomics, March 2014, Wolters Kluwer Health

    Professor Antonio Fernandez-Nebro

  145. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

    Article • Annals of the Rheumatic Diseases, January 2014, BMJ

    Professor Antonio Fernandez-Nebro

  146. Lack of validation of genetic variants associated with anti–tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis

    Article • Arthritis Research & Therapy, January 2014, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  147. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

    Article • Arthritis Research & Therapy, January 2014, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  148. Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

    Article • The American Journal of Human Genetics, January 2014, Elsevier

    Professor Antonio Fernandez-Nebro

  149. Incidence of Cancer in a Cohort of Spanish Patients With Systemic Lupus Erythematosus

    Article • Reumatología Clínica, November 2013, Elsevier

    Professor Antonio Fernandez-Nebro

  150. Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en el lupus eritematoso sistémico

    Article • Reumatología Clínica, September 2013, Elsevier

    Professor Antonio Fernandez-Nebro

  151. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci

    Article • Human Molecular Genetics, June 2013, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  152. GWAS replication study confirms the association of PDE3A–SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis

    Article • Pharmacogenomics, May 2013, Future Medicine

    Professor Antonio Fernandez-Nebro

  153. Reducing the Need for Central Dual-Energy X-Ray Absorptiometry in Postmenopausal Women: Efficacy of a Clinical Algorithm Including Peripheral Densitometry

    Article • Calcified Tissue International, April 2013, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  154. Quality-of-care standards for early arthritis clinics

    Article • Rheumatology International, April 2013, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  155. The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis

    Article • PLOS One, January 2013, PLOS

    Professor Antonio Fernandez-Nebro

  156. Baseline comorbidities in patients with rheumatoid arthritis who have been prescribed biological therapy: A case control study

    Article • Reumatología Clínica, January 2013, Elsevier

    Professor Antonio Fernandez-Nebro

  157. Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia

    Article • Arthritis Research & Therapy, January 2013, Springer Science + Business Media

    M.D.,Ph.D. Rubén Queiro, Professor Antonio Fernandez-Nebro

  158. Implication ofIL-2/IL-21region in systemic sclerosis genetic susceptibility

    Article • Annals of the Rheumatic Diseases, November 2012, BMJ

    Professor Antonio Fernandez-Nebro

  159. Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis

    Article • The Journal of Rheumatology, October 2012, The Journal of Rheumatology

    Professor Antonio Fernandez-Nebro

  160. Survival of Lupus Nephritis Patients After Renal Transplantation In Malaga

    Article • Transplantation Proceedings, September 2012, Elsevier

    Professor Antonio Fernandez-Nebro

  161. Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes

    Article • Human Molecular Genetics, July 2012, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro, M.D.,Ph.D. Rubén Queiro

  162. Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study

    Article • Lupus, July 2012, SAGE Publications

    Professor Antonio Fernandez-Nebro

  163. No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis

    Article • Tissue Antigens, June 2012, Wiley

    Professor Antonio Fernandez-Nebro

  164. Evaluation of a Shared Autoimmune Disease-associated Polymorphism of TRAF6 in Systemic Sclerosis and Giant Cell Arteritis

    Article • The Journal of Rheumatology, May 2012, The Journal of Rheumatology

    Professor Antonio Fernandez-Nebro

  165. Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up

    Article • Human Molecular Genetics, March 2012, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  166. Effectiveness of a clinical practice intervention in early rheumatoid arthritis

    Article • Arthritis Care & Research, February 2012, Wiley

    Professor Antonio Fernandez-Nebro

  167. Systemic Lupus Erythematosus: Genomics, Mechanisms, and Therapies

    Article • Clinical and Developmental Immunology, January 2012, Hindawi Publishing Corporation

    Professor Antonio Fernandez-Nebro

  168. Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis

    Article • Arthritis Research & Therapy, January 2012, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  169. Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis

    Article • Arthritis Research & Therapy, January 2012, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  170. A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis

    Article • Arthritis Research & Therapy, January 2012, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  171. A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators

    Article • Arthritis & Rheumatism, December 2011, Wiley

    Professor Antonio Fernandez-Nebro

  172. A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations

    Article • Human Molecular Genetics, November 2011, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  173. Tendencia anual de las artroplastias de rodilla y cadera en artritis reumatoide entre 1998-2007

    Article • Reumatología Clínica, November 2011, Elsevier

    Professor Antonio Fernandez-Nebro

  174. The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis

    Article • Genes & Immunity, October 2011, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  175. Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population

    Article • Rheumatology, August 2011, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  176. Erratum: Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    Article • Nature Genetics, May 2011, Springer Science + Business Media

    Professor Antonio Fernandez-Nebro

  177. Consenso de uso de rituximab en artritis reumatoide. Un documento con recomendaciones basadas en la evidencia

    Article • Reumatología Clínica, January 2011, Elsevier

    Professor Antonio Fernandez-Nebro

  178. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort

    Article • Annals of the Rheumatic Diseases, December 2010, BMJ

    Professor Antonio Fernandez-Nebro

  179. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis

    Article • Annals of the Rheumatic Diseases, December 2010, BMJ

    Professor Antonio Fernandez-Nebro

  180. Systemic Diseases: From Amyloidosis to CryoglobulinemiaHereditary fibrinogen A α-chain amyloidosis: Phenotypic characterization of a systemic disease and the role of liver transplantation. Blood 115: 2998–3007, 2010Long-term TNF-α blockade in patients ...

    Article • Clinical Journal of the American Society of Nephrology, October 2010, American Society of Nephrology

    Professor Antonio Fernandez-Nebro

  181. Experiencia con rituximab en el tratamiento de pacientes con lupus. La base de datos LESIMAB

    Article • Reumatología Clínica, September 2010, Elsevier

    Professor Antonio Fernandez-Nebro

  182. Long-term TNF-α Blockade in Patients with Amyloid A Amyloidosis Complicating Rheumatic Diseases

    Article • The American Journal of Medicine, May 2010, Elsevier

    Professor Antonio Fernandez-Nebro

  183. BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians

    Article • Annals of the Rheumatic Diseases, October 2009, BMJ

    Professor Antonio Fernandez-Nebro

  184. Amiloidosis

    Article • Medicine - Programa de Formación Médica Continuada Acreditado, May 2009, Elsevier

    Professor Antonio Fernandez-Nebro

  185. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

    Article • Annals of the Rheumatic Diseases, September 2008, BMJ

    Professor Antonio Fernandez-Nebro

  186. The use of rituximab to treat a patient with ankylosing spondylitis and hepatitis B

    Article • Rheumatology, August 2008, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  187. The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry

    Article • Rheumatology, April 2008, Oxford University Press (OUP)

    Professor Antonio Fernandez-Nebro

  188. Anti-Cofactor Autoantibodies in Systemic Lupus Erythematosus: Prevalence, Clinical and HLA Class II Associations

    Article • Immunological Investigations, January 2008, Taylor & Francis

    Professor Antonio Fernandez-Nebro

  189. Implementación y características de la población del estudio ArtRoCad, una aproximación al consumo de recursos y repercusión socioeconómica de la artrosis de rodilla y cadera en atención primaria

    Article • Reumatología Clínica, September 2006, Elsevier

    Professor Antonio Fernandez-Nebro

  190. Registrolesaf. Características de los pacientes con lupus eritematoso sistémico y síndrome antifosfolipídico registrados por usuarios médicos especialistas en reumatología y medicina interna

    Article • Reumatología Clínica, May 2006, Elsevier

    Professor Antonio Fernandez-Nebro

  191. Systemic lupus erythematosus in Europe at the change of the millennium: Lessons from the “Euro-Lupus Project”

    Article • Autoimmunity Reviews, March 2006, Elsevier

    Professor Antonio Fernandez-Nebro

  192. Errata

    Article • The American Journal of Medicine, February 2006, Elsevier

    Professor Antonio Fernandez-Nebro

  193. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists

    Article • The American Journal of Medicine, May 2005, Elsevier

    Professor Antonio Fernandez-Nebro

  194. Systemic lupus erythematosus in southern Spain: a comparative clinical and genetic study between Caucasian and Gypsy patients

    Article • Lupus, December 2004, SAGE Publications

    Professor Antonio Fernandez-Nebro

  195. Manifestaciones clínicas y alteraciones inmunológicas en pacientes con síndrome antifosfolipídico. Presentación de 112 casos

    Article • Medicina Clínica, October 2004, Elsevier

    Professor Antonio Fernandez-Nebro

  196. Manifestaciones clínicas y alteraciones inmunológicas en pacientes con síndrome antifosfolipídico. Presentación de 112 casos

    Article • Medicina Clínica, October 2004, Elsevier

    Professor Antonio Fernandez-Nebro

  197. Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period

    Article • Medicine, September 2003, Wolters Kluwer Health

    Professor Antonio Fernandez-Nebro

  198. HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus

    Article • Lupus, July 2003, SAGE Publications

    Professor Antonio Fernandez-Nebro

  199. HLA Class II DNA Typing in a Large Series of European Patients with Systemic Lupus Erythematosus

    Article • Medicine, May 2002, Wolters Kluwer Health

    Professor Antonio Fernandez-Nebro

  200. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

    Article • Arthritis & Rheumatism, April 2002, Wiley

    Professor Antonio Fernandez-Nebro

  201. Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients

    Article • Medicine, May 1999, Wolters Kluwer Health

    Professor Antonio Fernandez-Nebro

  202. Localized rheumatoid vasculitis presenting as acute alithiasic cholecystitis

    Article • The American Journal of Medicine, July 1991, Elsevier

    Professor Antonio Fernandez-Nebro

  203. Psoas abscess secondary to brucellosis

    Article • Journal of Infection, January 1991, Elsevier

    Professor Antonio Fernandez-Nebro